Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Arch Cardiovasc Dis ; 101(4): 235-41, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18654098

RESUMO

PURPOSE: Evaluate heart failure management in a Military Hospital in 2005. METHODS: Retrospective audit of 46 case records of patients hospitalised with heart failure within the framework of an accreditation procedure. RESULTS: The left ventricular ejection fraction was evaluated in 85% of cases during the reference hospital stay. Systolic heart failure was detected in 63% of cases. At least one NT-proBNP assay was performed for each patient. A global assessment was systematically performed, except for the mini mental state examination in patients aged over 75 years who represented 80% of patients. Initial therapeutic education was provided for 50% of systolic heart failure patients. Prescription rates in systolic heart failure were 76% for angiotensin-converting enzyme inhibitors, 7% for angiotensin receptor antagonists; 84% for at least one medicinal product in the above 2 classes; 68% for beta-blockers and 32% for spironolactone. A hospital discharge report was available for 93% of the patients. Elective re-admissions to hospital for uptitration of treatment concerned 10% of systolic heart failure patients. Emergency hospital re-admissions after a cardiovascular event (usually decompensation), concerned 35% of patients, after an average duration of one year of follow-up. These latter re-admissions, often repeated, led to 4% of additional hospital deaths. The initial hospital mortality rate was 13%. CONCLUSION: Therapeutic patient education is under development. Medication may still be optimised, both qualitatively and quantitatively. Surveillance is planned with a yearly audit.


Assuntos
Insuficiência Cardíaca/tratamento farmacológico , Auditoria Médica , Antagonistas Adrenérgicos beta/uso terapêutico , Bloqueadores do Receptor Tipo 1 de Angiotensina II/uso terapêutico , Dieta , Diuréticos/uso terapêutico , Uso de Medicamentos , Seguimentos , França/epidemiologia , Insuficiência Cardíaca/diagnóstico , Insuficiência Cardíaca/etiologia , Mortalidade Hospitalar , Hospitalização , Hospitais Militares , Humanos , Estilo de Vida , Peptídeo Natriurético Encefálico/sangue , Educação de Pacientes como Assunto , Readmissão do Paciente/estatística & dados numéricos , Fragmentos de Peptídeos/sangue , Garantia da Qualidade dos Cuidados de Saúde , Estudos Retrospectivos , Espironolactona/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...